Secreted Frizzled Related Proteins in Cardiovascular and Metabolic Diseases

Front Endocrinol (Lausanne). 2021 Aug 20:12:712217. doi: 10.3389/fendo.2021.712217. eCollection 2021.

Abstract

Abnormal gene expression and secreted protein levels are accompanied by extensive pathological changes. Secreted frizzled related protein (SFRP) family members are antagonistic inhibitors of the Wnt signaling pathway, and they were recently found to be involved in the pathogenesis of a variety of metabolic diseases, which has led to extensive interest in SFRPs. Previous reports highlighted the importance of SFRPs in lipid metabolism, obesity, type 2 diabetes mellitus and cardiovascular diseases. In this review, we provide a detailed introduction of SFRPs, including their structural characteristics, receptors, inhibitors, signaling pathways and metabolic disease impacts. In addition to summarizing the pathologies and potential molecular mechanisms associated with SFRPs, this review further suggests the potential future use of SFRPs as disease biomarkers therapeutic targets.

Keywords: SFRPs; adipocyte; cardiovascular disease; metabolism disease; obesity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases* / pathology
  • Cardiovascular Diseases* / physiopathology
  • Gene Expression
  • Humans
  • Intracellular Signaling Peptides and Proteins / chemistry
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / physiology*
  • Metabolic Diseases* / metabolism
  • Neovascularization, Physiologic
  • Wnt Proteins / metabolism
  • Wnt Signaling Pathway
  • beta Catenin / metabolism

Substances

  • Intracellular Signaling Peptides and Proteins
  • Wnt Proteins
  • beta Catenin